Literature DB >> 17083691

Hidradenocarcinoma: a histological and immunohistochemical study.

Christine J Ko1, Alistair J Cochran, William Eng, Scott W Binder.   

Abstract

The diagnosis of hidradenocarcinoma is difficult due to a combination of factors including inconsistent nomenclature/ classification, rarity of the neoplasm, and variable morphology of cells composing the neoplasm. Immunohistochemistry has not been previously performed on a series of hidradenocarcinomas. We evaluated six cases of hidradenocarcinoma histologically and immunohistochemically using antibodies to gross cystic disease fluid protein-15 (GCDFP-15), carcino-embryonic antigen (CEA), epithelial membrane antigen (EMA), S-100 protein, keratin AE1/3, cytokeratin 5/6, p53, bcl-1, bcl-2, and Ki67. Histology suggested concurrent eccrine and apocrine differentiation of the cases. Ki67 and p53 staining was strongly positive in five of six tumors. The neoplasms stained with antibodies to CEA, S-100 protein, GCDFP-15, EMA, bcl-1, and bcl-2 in no consistent pattern. All tumors studied stained positively for keratin AE1/3 and cytokeratin 5/6. In making the diagnosis of hidradenocarcinoma, it may be unnecessary to separate hidradenocarcinoma into eccrine and apocrine categories, and although Ki67 and p53 may be helpful, histological parameters remain paramount.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083691     DOI: 10.1111/j.1600-0560.2006.00536.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  10 in total

1.  Diagnosis and treatment of clear cell hidradenocarcinoma of the scalp.

Authors:  Kai Shu; Qungen Xiao; Fabian Büchele; Suojun Zhang; Wei Jiang; Ting Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

2.  Mucin-producing Malignant Tumor of Lower Eyelid Presenting in a 14-year-old Patient.

Authors:  Andrea Latorre; Lana Alghothani; David Lambert; Kris R Jatana; Sara Peters; Jill Foster; Robert Hill
Journal:  J Clin Aesthet Dermatol       Date:  2012-04

3.  Cytological features of malignant eccrine acrospiroma presenting as a soft tissue mass axilla: A rare sweat gland tumor with histologic correlation.

Authors:  Pinki Pandey; Alok Dixit; Subrat Chandra; Aparna Tanwar
Journal:  Int J Appl Basic Med Res       Date:  2015 May-Aug

4.  Apocrine hidradenocarcinoma of the scalp: a classification conundrum.

Authors:  Marc Cohen; David S Cassarino; Hubert B Shih; Elliot Abemayor; Maie St John
Journal:  Head Neck Pathol       Date:  2008-12-05

5.  Malignant nodular hidradenoma of scalp.

Authors:  Tanmoy Maiti; Sampath Somanna; Bhagavatula Indira Devi; Asha Unchagi; Dhaval Shukla
Journal:  J Neurosci Rural Pract       Date:  2014-10

6.  Metastatic hidradenocarcinoma: Surgery and chemotherapy.

Authors:  Trabelsi Amel; Gharbi Olfa; Hammedi Faten; Hochlef Makrem; Ben Ahmed Slim; Mokni Moncef
Journal:  N Am J Med Sci       Date:  2009-12

Review 7.  Current management approach to hidradenocarcinoma: a comprehensive review of the literature.

Authors:  Abhishek Soni; Nupur Bansal; Vivek Kaushal; Ashok Kr Chauhan
Journal:  Ecancermedicalscience       Date:  2015-03-19

8.  Hidradenocarcinoma: Five Years of Local and Systemic Control of a Rare Sweat Gland Neoplasm with Nodal Metastasis.

Authors:  Benazir Mir Khan; Muhammad Atif Mansha; Nasir Ali; Ahmed Nadeem N Abbasi; Syed Mustajab Ahmed; Bilal M Qureshi
Journal:  Cureus       Date:  2018-06-26

9.  Malignant Nodular Hidradenoma of the Left Knee: A Malignant Mystery With an Overview of Literature.

Authors:  Narendhar Gokulanathan; Pandjatcharam Jagadesan; Kalaranjani M; Rajesh Nachiappa Ganesh
Journal:  Cureus       Date:  2022-07-29

10.  Prognostic analysis of hidradenocarcinoma: a SEER-based observational study.

Authors:  Teng Gao; Sheng Pan; Meng Li; Runping Su
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.